EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Hepatitis D Testing in Canada Identifies More HDV ‐Positive Individuals: A Multi‐Provincial Analysis, 2022–2024

Emma R. Lee, Jacqueline Day, Carla Osiowy, Vanessa Tran, Rachel Ha, Carmen Charlton, Derek Stein, Josh Titus, Christopher F. Lowe, Nancy Matic, Todd F. Hatchette, Donald G. Murphy und 1 weitere

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 19.11.2026. Verfasst von Emma R. Lee und 12 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims CASL/AMMI 2025 guidelines recommend reflex anti‐HDV testing for all hepatitis B surface antigen (HBsAg)‐positive individuals, replacing risk‐based screening, yet Canadian data on HDV testing and detection remain limited. In Canada, only Quebec offers anti‐HDV testing; other regions refer samples to the National Microbiology Laboratory (NML), where HDV RNA confirmation is centralised. We assessed HDV testing volume, seroprevalence, RNA positivity, and genotypes in referred samples and randomly selected archived HBsAg‐positive samples.

Methods

Anti‐HDV results from Quebec and the NML from August 2022 to July 2024 were analysed and compared with a 2012–2019 national survey. To complement referral‐based surveillance, 3386 randomly selected archived HBsAg‐positive samples from five provinces were tested. Seropositive samples underwent HDV RNA testing and genotyping at NML.

Results

Among 8401 unique referred samples, 271 (3.2%; 95% CI, 2.9–3.6) were anti‐HDV positive, of which 117 (43.2%; 95% CI, 37.4–49.1) were HDV RNA positive. Compared with 2012–2019, annual testing volume increased fourfold (1011 to 4201 tests/year), while annual detection increased from 48 to 136 anti‐HDV‐positive individuals and from 31 to 59 HDV RNA‐positive individuals. Among archived samples, 67/3386 (2.0%; 95% CI, 1.6–2.5) were anti‐HDV positive, and 14/67 (20.9%; 95% CI, 12.9–32.1) were RNA positive. Genotypes 1, 2, 5, 7, and 8 were detected.

Conclusions

Increased HDV testing in Canada was associated with greater detection of anti‐HDV‐positive and HDV RNA‐positive individuals despite lower positivity rates. HDV RNA detection and multiple genotypes in archived HBsAg‐positive samples support universal reflex anti‐HDV testing, with RNA confirmation, harmonised reporting, and integrated HBV/HDV surveillance.

Förderung

  • Gilead Sciences

Zitieren

APA

Lee, E. R., Day, J., Osiowy, C., Tran, V., Ha, R., Charlton, C., Stein, D., Titus, J., Lowe, C. F., Matic, N., Hatchette, T. F., Murphy, D. G., & Coffin, C. S. (2026). Increased Hepatitis D Testing in Canada Identifies More HDV ‐Positive Individuals: A Multi‐Provincial Analysis, 2022–2024. Liver International, 46(12). https://doi.org/10.1111/liv.70916

Vancouver

Lee ER, Day J, Osiowy C, Tran V, Ha R, Charlton C, et al. Increased Hepatitis D Testing in Canada Identifies More HDV ‐Positive Individuals: A Multi‐Provincial Analysis, 2022–2024. Liver International. 2026;46(12). doi:10.1111/liv.70916

BibTeX
@article{Lee2026,
  author = {Lee, Emma R. and Day, Jacqueline and Osiowy, Carla and Tran, Vanessa and Ha, Rachel and Charlton, Carmen and Stein, Derek and Titus, Josh and Lowe, Christopher F. and Matic, Nancy and Hatchette, Todd F. and Murphy, Donald G. and Coffin, Carla S.},
  title = {Increased Hepatitis D Testing in Canada Identifies More HDV ‐Positive Individuals: A Multi‐Provincial Analysis, 2022–2024},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70916}
}
Kostenlos starten →